MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-BR-26-0033400
Callisto Pharmaceuticals Private Limited
Callisto Pharmaceuticals Private Limited - trading in Patna, Bihar, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹48.03 Lakh
▼ 6% YoY
Net profit · FY 2025
₹2.27 Lakh
Net margin 4.7%
EBITDA · FY 2025
₹2.39 Lakh
EBITDA margin 5%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹2 Lakh
Issued & subscribed
Open charges
₹20 Lakh
Secured borrowings
Company age
17 yrs
Est. 2009
Directors on board
2
As per MCA filings
About Callisto Pharmaceuticals Private Limited
Data last updated:
Callisto Pharmaceuticals Private Limited is a private limited company based in Patna, Bihar, India. It operates in the wholesale trading and distribution segment of the trading and commerce sector. It was incorporated on 10 September 2009 and has been in existence for over 17 years.
The company is registered with the Registrar of Companies (ROC), Patna, under CIN U85100BR2009PTC014828.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹2 Lakh. It is led by directors Mala Verma and Rajesh Sinha.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Shop No. 2 Shastri Place R.K. Avenue P.O. – Bankipur P.S. – Kadamkuan, Patna, Bihar, India – 800004.
As per the financials filed for FY 2025, the company reported a revenue of ₹48.03 Lakh, a decline of 6% compared to the previous year. For the same year it recorded a net profit of ₹2.27 Lakh (net margin 4.7%) and EBITDA of ₹2.39 Lakh (EBITDA margin 5%). Revenue has declined at a compounded annual rate (CAGR) of 5% over three years and 10% over five years.
As per MCA filings, the company has open charges of ₹20 Lakh on record.
Callisto Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-BR-26-0033400). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U85100BR2009PTC014828
Registration Number 014828
Incorporation Date 10 September 2009
ROC Patna
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-BR-26-0033400
Key People
Mala Verma Director Rajesh Sinha Director Recognitions & Rankings of Callisto Pharmaceuticals
Contact details
Callisto Pharmaceuticals Private Limited's registered office is in Patna, Bihar. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressShop No. 2 Shastri Place R.K. Avenue P.O. – Bankipur P.S. – Kadamkuan, Patna, Bihar, India – 800004
- IndustryTrading, Wholesale, Other Wholesale
To see the full contact details of Callisto Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Callisto Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Callisto Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Callisto Pharmaceuticals Private Limited, buy the company report.
Financials of Callisto Pharmaceuticals Private Limited
FY 2025 filings availableCallisto Pharmaceuticals Private Limited reported revenue of ₹48.03 Lakh (down 6% YoY) for FY 2025.
Revenue · FY 2025
₹48.03 Lakh ▼ 6%
Net profit · FY 2025
₹2.27 Lakh margin 4.7%
EBITDA · FY 2025
₹2.39 Lakh margin 5%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 6%
3 years · compounded
▼ 5%
5 years · compounded
▼ 10%
EBITDA CAGR growth
1 year
▲ 52%
3 years · compounded
▼ 9%
5 years · compounded
▼ 7%
Revenue has declined at a compounded annual rate (CAGR) of 10% over five years, including a 6% fall in the latest year. EBITDA rose 52% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹2.39 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹2.27 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5% | ||||
| Net Profit Margin | 4.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Callisto Pharmaceuticals Private Limited, buy the company report.
Board of directors of Callisto Pharmaceuticals Private Limited
Callisto Pharmaceuticals has 2 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mala Verma | Director | 10 Sep 2009 | 17 Years 1 Months | Current |
| Rajesh Sinha | Director | 10 Sep 2009 | 17 Years 1 Months | Current |
Peer comparison
Callisto Pharmaceuticals Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Rhetoric Remedies Private Limited | ₹48.12 Lakh (FY 2024) | 9.0% | Varanasi, Uttar Pradesh, India | |||
| Suryaanjan Pharmaceuticals India Private Limited | ₹48.03 Lakh (FY 2024) | 4.0% | Jaipur, Rajasthan, India | |||
| Callisto Pharmaceuticals Private Limitedthis company | ₹48.03 Lakh (FY 2025) | ₹2.27 Lakh | 4.7% | -6.0% | Patna, Bihar, India | |
| Akmma Laboratories Private Limited | ₹48.01 Lakh (FY 2025) | -87.0% | Kolkata, West Bengal, India | |||
| Vetbac Pharmaceuticals Private Limited | ₹47.93 Lakh (FY 2024) | 7.0% | Patna, Bihar, India | |||
| Veda Cure Private Limited | ₹47.82 Lakh (FY 2025) | 1.0% | Indore, Madhya Pradesh, India |
To see the full peer comparison of Callisto Pharmaceuticals Private Limited, buy the company report.
Auditor
Callisto Pharmaceuticals Private Limited is audited by VIKRAMADITYA SINHA for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| VIKRAMADITYA SINHA | FY 2017 | 083964 |
Shareholding
The shareholding of Callisto Pharmaceuticals Private Limited is on record for FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Foreign institutional investors (FII) | |
| Public | |
| Others |
To see the full shareholding pattern of Callisto Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
₹20 Lakh
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 14 Jan 2011 | 10263016 | State Bank of India | ₹20 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Callisto Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Callisto Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Callisto Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Callisto Pharmaceuticals Private Limited has 2 board changes on record since 2009: 2 appointments. The latest: Mala Verma was appointed as Director on 10 Sep 2009.
AGM
Callisto Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Callisto Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Patna.
Charges
A charge with State Bank Of India amounted to Rs. 20.00 Lakh with Charge ID 10263016 was registered on 14 Jan 2011.
Appointed
Mala Verma was appointed as Director.
Appointed
Rajesh Sinha was appointed as Director.
Incorporation
10 Sep 2009
Callisto Pharmaceuticals Private Limited was registered on 10 Sep 2009 with Roc Patna & aged 17 years 2 months as per MCA records.
Frequently asked questions
Callisto Pharmaceuticals is an active private limited company based in Patna, Bihar, India. The company works in wholesale, within the trading industry. It was incorporated on 10 September 2009 (17+ years old) and is registered under CIN U85100BR2009PTC014828.
Callisto Pharmaceuticals has 2 current directors:
- Mala Verma - Director
- Rajesh Sinha - Director
The latest financial statements of Callisto Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The CIN (Corporate Identification Number) of Callisto Pharmaceuticals is U85100BR2009PTC014828. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Callisto Pharmaceuticals was incorporated on 10 September 2009, making it 17+ years old. It is registered with the Registrar of Companies, Patna.
The peers of Callisto Pharmaceuticals by revenue are Rhetoric Remedies Private Limited, Suryaanjan Pharmaceuticals India Private Limited, Akmma Laboratories Private Limited, Vetbac Pharmaceuticals Private Limited, Veda Cure Private Limited, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading).
Mala Verma was appointed as Director on 10 Sep 2009. Rajesh Sinha was appointed as Director on 10 Sep 2009.
Yes, Callisto Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-BR-26-0033400).
The registered office of Callisto Pharmaceuticals is at Shop No. 2 Shastri Place R.K. Avenue P.O. – Bankipur P.S. – Kadamkuan, Patna, Bihar, India – 800004.
Callisto Pharmaceuticals operates in the trading industry, in the wholesale segment.
Callisto Pharmaceuticals has open charges of ₹20 Lakh and no satisfied charges on record as per latest MCA filings.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages